Premier Alternatives

InSilico Medicine Cayman (HKG: 03696)

Biotech · Hong Kong, MA · Founded 2014 · Publicly Held

InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. InSilico Medicine Cayman (HKG: 03696) is based in Hong Kong, MA and was founded in 2014. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.7 billion (Dec 2025). It has raised $842 million across 6 recorded rounds; the latest was a $13 million Series E extension (final close) in Jun 2025.

Last price · $/share
—
Implied valuation
$1.7B
Total raised
$841.9M
Last round
Series E extension (final close)
Jun 2025

Leadership

3
+ 2 more people (board, observers, advisors) · free account shows everyone

Membership and data by Private Market View

Who runs InSilico Medicine Cayman (HKG: 03696)

5 people are listed on the InSilico Medicine Cayman (HKG: 03696) team: 3 executives and 2 board members, including Alex Zhavoronkov (Founder) and Feng Ren (Co-CEO). 2 of them have a verified direct contact on file.

Free account
More of InSilico Medicine Cayman (HKG: 03696) with a free account
  • ·The complete investor list: 50 names
  • ·Watch InSilico Medicine Cayman (HKG: 03696): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Contact database
Verified contact details, revealed on demand

2 of the people at InSilico Medicine Cayman (HKG: 03696) have a verified contact on file. Plus members reveal 10 contacts a month, Pro members 200.

Unlock contact reveals

Membership and data by Private Market View